Clover Health Stock Soars to Intraday High with 16.43% Surge

Clover Health Investments Corp., a small-cap player in the insurance industry, has experienced a significant surge in its stock price, gaining 16.43% on May 28, 2026. The stock reached an intraday high of USD 4.22, reflecting a strong performance relative to the broader market, where the S&P 500 only increased by 0.58% on the same day. Over the past month, Clover Health has shown remarkable growth, with a 58.33% increase compared to the S&P 500's 5.95%. Year-to-date, the stock has soared by 77.87%, significantly outperforming the S&P 500's 10.49% gain. However, despite these short-term gains, the company has faced challenges in long-term performance, with a return on equity of -16.93% and a five-year decline of 45.29%. Clover Health's recent financial results indicate a robust net sales figure of USD 749.19 million, alongside a notable operating cash flow of USD 57.26 million. The company also reported a year-over-year increase in net sales of 53.61%. With institutional holdings at 34.4%, Clover Health continues to attract attention, although it has underperformed the market over the past year, generating a return of 11.84% compared to the S&P 500's 27.00%.